We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LTTS:NSEL&T Technology Services Ltd. Analysis

Data as of 2026-09-08 - not real-time

₹3,421.70

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

At INR 3,421.70, L&T Technology Services Limited shows no decisive moving-average alignment, leaving the trend neutral. Over a rolling month the price has lost 2.2%. RSI sits at 40.1, which reads as neutral, and MACD momentum is bearish. Watch INR 3,385.00 as support and INR 3,708.00 as the nearer resistance level.
Valuation screens as fair: a P/E of 28.4 sits below the sector average of 33.2. The average analyst target implies 4.2% above today's level. Revenue is growing at 2.6% on a 11.7% profit margin. The 1.66% dividend yield looks covered by current payout levels.
Risk scores 4 out of 10, which is moderate for this asset class. With 30-day volatility of 22.4%, a beta of 0.36 and a maximum drawdown of 35.1%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
This one splits by horizon — sell in the near term, hold further out, at 3/10 long-term conviction.

Top Market Events

L&T Technology Services LTTS reported consolidated revenue of Rs 2,756.BusinessWire IndiaMumbai Maharashtra India , July 15: L&T Technology Services Limited BSE: 540115, NSE: LTTS , a global...L&T Technology Services Limited BSE: 540115, NSE: LTTS , a global leader in Engineering Intelligence Solutions & ER&D...

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 5/10

Key Factors

  • Trading below the 200-day average of 3665.41
  • MACD momentum is negative
  • Maximum drawdown of 35.1%

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • P/E of 28.4 versus sector average of 33.2
  • Trading below the 200-day average of 3665.41
  • MACD momentum is negative

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 28.4 versus sector average of 33.2
  • Dividend yield of 1.66%
  • Price-to-book of 5.60

Key Metrics & Analysis

Financial Health

Revenue Growth2.60%
Profit Margin11.68%
P/E Ratio28.4
Debt/Equity8.91
P/B Ratio5.6
Industry P/E33.2

Technical Analysis

TrendNeutral
RSI40.1
Support₹3,385.00
Resistance₹3,708.00
MA 20₹3,549.80
MA 50₹3,450.60
MA 200₹3,665.41
MACDBearish
VolumeStable
Fear & Greed Index94.11

Valuation

Target Price₹3,566.03
Upside/Downside4.22%
GradeFair
TypeBlend
Dividend Yield1.66%

Risk Assessment

Beta0.36
Volatility22.37%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.